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When normal human fibroblasts are exposed in vitro to ionizing
radiation, a proportion of the cells in the G1 phase of the cell cycle
suffer a dose-dependent reduction in their ability to progress
further through the cell cycle (Little and Nagasawa, 1985). We
have shown (Williams et al, 1997; Boyle et al, 1999) that the
extent of this permanent G1 arrest is less pronounced in fibroblasts
of patients with the Li-Fraumeni (LF) syndrome carrying inher-
ited, heterozygous mutations of the TP53 gene which confer a high
risk of cancer (reviewed by Varley et al, 1997). Our results are
consistent with the hypothesis that p53 is responsible for moni-
toring the integrity of the genome (Lane, 1992) and eliminating
genetically damaged cells that might otherwise be predisposed to
malignant conversion. 
In some cell types, apoptosis appears to be the functional equiv-
alent of G1 arrest and is reduced or eliminated in p53-defective
cells after exposure to DNA-damaging agents (references in
Williams et al, 1996, 1997; Camplejohn et al, 1995). For example,
a cell line of human lymphocyte origin carrying a TP53 mutation
showed less radiation-induced apoptosis than an isogenic cell line
without the mutation (Schwartz et al, 1995) although neither line
sustained G1 arrest (Little et al, 1995). The mutant cell line exhib-
ited more structural chromosome damage at the first mitosis after
G1 irradiation than the wild type cells and Schwartz and colleagues
(Schwartz et al, 1995; Schwartz and Jordan, 1997) suggested that
the cells with the most chromosome damage were selectively
eliminated by pre-mitotic apoptosis in the p53-proficient line. 
The hypothesis of Schwartz et al, if extended to cells with
reduced permanent G1 arrest, would predict that fibroblasts of LF
patients with germline TP53 mutations would exhibit more chro-
mosome damage at their first mitosis after G1 irradiation than
normal fibroblasts. Only about half of the families with the LF
syndrome are found to carry inherited TP53 mutations (Varley
et al, 1997) and we have shown that fibroblasts from non-mutation
cases have no defect in G1 arrest after irradiation (Boyle et al,
1999) and might not, therefore, be expected to show enhanced
chromosomal radiosensitivity of G1 cells. In the present study we
have investigated the G1 chromosomal radiosensitivity of fibrob-
lasts from 7 normal donors, 9 LF patients with TP53 mutations and
6 without mutations. 
MATERIALS AND METHODS 
Full details of the cell strains used are given in Boyle et al (1998,
1999, 2000). The maximum number of in vitro population
doublings (PD) was previously established for each strain and all
were irradiated before they had reached 80% of their maximum
PD, because LF strains tend to become chromosomally unstable
during the last 20% of their proliferative lifetime (Boyle et al
1998, 2000). 
Designations of the strains, which were all established in this
laboratory, are as follows. 
Group 1 (normal controls); 83MA, 84MA, 105MA, 120MA,
162MA, 177MA, 187MA. 
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138MA, 178MA, 185MA, 191MA, 193MA. These 9 strains were
established from 7 LF families each with different TP53 mutations
(Boyle et al, 1999). LF families have been subdivided into clas-
sical (LFS) and LF-like (LFL) depending upon the number of indi-
viduals with cancer, the nature of the cancers, their time of onset
and other criteria (Varley et al, 1997). Group 2 comprised 5 LFS
and 2 LFL families. 
Group 3 (non-mutation carriers); 80MA, 107MA, 121MA,
126MA, 128MA, 147MA. The 6 strains were from different LF
families (3 LFS and 3 LFL) and all were from patients with expe-
rience of cancers typical of those in LF families (e.g. sarcomas and
breast cancer), except strain 121MA which was from an unaf-
fected brother of a patient with a typical LF cancer. Strain 121MA
was included because at late passage (>90% maximum PD) it
showed the spontaneous chromosomal instability seen in ageing LF
strains from cases with typical LF-type cancers (Boyle et al, 2000).
To produce a G1 population, cells were grown to confluence in
Minimal Essential Medium with Earle’s salts (MEM) and 15% fetal
calf serum (FCS) without antibiotics and maintained at confluence
with twice weekly medium changes for 10–14 days. 2 days before
irradiation the medium was changed to MEM with 0.1% FCS. On the
day of irradiation, cells were harvested by trypsinisation, counted, and
exposed in suspension (approximately 1 ´ 106 per ml) to 0 or 3 Gy
137Cs gamma irradiation at a dose rate of 3.3 Gy per min. Cells were
then seeded at 1 ´ 106 per T150 flask (Corning) in complete medium.
At 16 h after seeding, before cells had entered their first mitosis
(Williams et al, 1997), colcemid (150 ng ml–1) was added to arrest
cells at their first metaphase and incubation was continued for a
further 50 h at which time metaphase preparations were made by
normal procedures. Cells were stained with Giemsa. 
For each cell strain 50–100 metaphases were scored for struc-
tural aberrations from coded slides of irradiated and non-irradiated
cells with 45 or 46 chromosomes. 
Measurement of permanent G1 arrest was made previously
(Williams et al, 1997; Boyle et al, 1999). Briefly, G1 cells were
irradiated or mock-irradiated, subcultured in medium containing
tritiated thymidine to label cells entering the S phase, harvested at
intervals between 60–120 hours post-irradiation and prepared for
autoradiography. The extent of permanent arrest was determined
by comparing the proportions of labelled cells in irradiated and
non-irradiated samples. 
The Mann–Whitney U test was used to test the significance of
differences in endpoints between groups of strains. 
RESULTS 
Mean aberration yields and the range of values for irradiated and
non-irradiated cells of each of the 3 groups are given in Table 1,
together with values for the degree of permanent G1 arrest. 
The spontaneous aberration yield in the normal stains was
approximately 5% and was slightly, but not significantly, higher in
the other 2 groups. Further details of spontaneous structural and
numerical aberrations in these strains as they progress to senes-
cence are given in Boyle et al (1998, 2000). 
The majority of induced aberrations (subtracting the sponta-
neous yields) were of the chromosome type, comprising dicentrics,
centric rings and excess acentric fragments (see footnote 4 of Table 1),
typical of cells irradiated in G1. Approximately 15% of the induced
aberrations were of the chromatid type (mainly breaks and large
gaps), possibly indicating the presence of a small proportion of
cells in S and G2 at the time of irradition and/or arising from DNA
base damage in G1 cells (Schwartz and Russell, 1999). 
As we reported earlier (Williams et al, 1997; Boyle et al, 1999),
the average degree of G1 arrest was significantly less (P < 0.01) in
mutation-carrying strains (group 2, 44.6 ± 16.3%) than in normals
(group 1, 75.0 ± 13.0%). In contrast, the mean frequency of total
aberrations induced in group 2 strains (74.4 ± 12.7 per 100 cells)
was approximately 50% higher (P = 0.02) than in normals
(50.0 ± 16.2). This difference was seen for all types of aberrations. 
The average extent of G1 arrest in non-TP53 mutation-carrying
strains (group 3, 73.0 ± 7.4%) was very similar (P = 0.67) to that
of normals (75.0 ± 13.0%), as previously reported (Boyle et al,
1999). However, the mean yield of total aberrations (98.7 ± 42.6
per 100 cells) in group 3 was almost 100% higher (P < 0.01) than
in normals (50.0 ± 16.2), for all aberration types (Table 1).
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Table 1 Chromosomal aberration yields and the extent of G1 arrest in the 3 groups of cell strains 
Group Dose (Gy) Chromosome-type aberrations1
Chromatid Total
G1 arrest (%)2
Dicentrics Rings Acentrics4 Total aberrations aberrations
1. Normals 0 0 ± 0 0 ± 0 1.3 ± 1.3 1.3 ± 1.3 3.2 ± 2.1 4.6 ± 2.2  –
(n = 7) (0 – 3) (0 – 3) (0 – 6) (2 – 8) 
3 17.1 ± 15.5 5.4 ± 5.4 19.6 ± 8.1 42.1 ± 19.5 11.1 ± 5.8 53.1 ± 20.4 75.0 ± 13.0 
(4 – 44) (0 – 16) (12 – 34) (20 – 68) (5 – 18) (30 – 85) (50.2 – 90.9) 
2. Mutation carriers 0 0.67 ± 1.4 0 ± 0 1.0 ± 2.6 1.7 ± 2.7 3.6 ± 2.9 5.2 ± 3.8 
(n = 9)5 (0 – 4) (0 – 8) (0 – 8) (0 – 10) (2 – 14) 
3 29.4 ± 15.0 7.9 ± 2.5 29.0 ± 15.9 66.3 ± 12.4 15.0 ± 9.7 81.0 ± 14.7 44.6 ± 16.33
(14 – 59) (4 – 12) (4 – 54) (54 – 88) (6 – 26) (64 – 114) (14.9 – 63.5) 
3. Non-mutation carriers 0 0 ± 0 0 ± 0 1.3 ± 1.6 1.3 ± 1.6 6.3 ± 4.1 7.7 ± 4.1  –
(0 – 4) (0 – 4) (2 – 14) (6 – 16) 
3 39.7 ± 20.9 10.7 ± 6.2 37.0 ± 10.3 87.3 ± 27.7 19.7 ± 17.8 106.3 ± 46.5 73.0 ± 7.4 
(n = 6) (16 – 72) (4 – 20) (22 – 50) (58 – 140) (6 – 58) (66 – 198) (58.7 – 79.4) 
1 Aberration yields are expressed per 100 cells ± SD. Ranges are given in brackets. 50–100 cells scored from each sample except for irradiated cells from
normal strain 187MA where only 30 cells could be analysed. 2 Data from Boyle et al (1999). 3 G1 arrest data for 185MA are not included because they were
obtained after a dose of 4.0 Gy (Varley et al, 1998), but the 3.0 Gy data for 178MA are from the same family. 4 One acentric fragment was allocated to each
dicentric and ring. The remaining (excess) acentric fragments are given in this column. 5 Details of mutations given in Boyle et al (1999) except for strain
185MA, which was from family 2635 (see Table 1 in Boyle et al, 1999). Because of the wide range of aberration yields in group 3, giving a
comparatively large standard deviation, the mean yield was not
significantly greater than that of group 2 (P = 0.15). Within group
3, strain 80MA showed a considerably higher frequency of both
spontaneous (16/100 cells) and induced (182/100 cells) aberra-
tions than the 5 remaining strains, all of which had a spontaneous
yield of 6/100 cells and a range of induced yields from 60–96/100
cells. The mean frequency in the 5 strains was 82.0 ± 13.4 per 100
cells which was still significantly higher (P = 0.01) than the
normals. Strain 80MA also had the lowest level of G1 arrest
(58.7%) amongst group 3, the remaining 5 of which had a range
from 72.8 to 79.4% (mean 73.0 ± 7.4%). Strain 80MA has now
been found to carry a germline mutation in the hCHK2 gene (Bell
et al, 1999) which is likely to be involved in G1 checkpoint control
because of its influence on p53 transcription (see Discussion). 
DISCUSSION 
Our results support the hypothesis of Schwartz and colleagues
(Schwartz et al, 1995; Schwartz and Jordon, 1997) that p53-
proficient cells have a mechanism for selectively eliminating cells
with high levels of chromosome damage induced in the G1 phase
of the cell cycle. However, whereas in the cells of lymphoid origin
used by Schwartz et al this selection process occurs by apoptosis,
in human fibroblasts the mechanism appears to involve permanent
G1 arrest. During the course of our studies, Schwartz and Russell
(1999) have reported finding increased levels of chromosome
damage at the first mitosis after gamma-irradiation of a human
adenocarcinoma cell line in which permanent G1 arrest was elimi-
nated by transfection with the human papillomavirus type 16 E6
gene which inactivates p53 expression. 
There is abundant evidence that radiation-induced DNA double
strand breaks (dsb) can act as a signal for p53-dependent perma-
nent G1 arrest (references in Schwartz and Russell, 1999). Our
observations and those of Schwartz and Russell on non-lymphoid
cells provide additional support for this concept, since radiation-
induced chromosome aberrations arise mainly from dsb (reviewed
by Pfeiffer et al, 2000). These results suggest that a certain
minimal level of dsb is required before the signal for arrest is acti-
vated and that p53-defective cells have a higher signal threshold
than p53-proficient cells. Dsb that do not cause G1 blockage can
progress to mitosis and appear as simple deletions (excess frag-
ments) or interact to for, exchange aberrations (e.g. dicentrics and
rings). Schwartz and Russell (1999) argue that the increase in
chromatid aberrations, which they also observed in irradiated
HPV16-E6 cells compared with non-transfected cells, is a conse-
quence of deficient base excision repair that has been reported in
p53-defective human fibroblasts (Ford et al, 1998). 
There have been several other studies (Parshad et al, 1993, Lee
et al, 1994, Williams, et al, 1997), including our own (Wang et al,
1996, Mitchell and Scott, 1997, Varley et al, 1998) in which p53-
defective cells have been found to have elevated levels of radia-
tion-induced structural chromosome damage compared with
p53-proficient cells. However, in these investigations, cells were
either irradiated as asynchronous populations or in the G2 phase of
the cell cycle. In the former, the specific role of G1 arrest in deter-
mining these increased yields could not be assessed. The latter
results demonstrate that in p53-defective cells it is not only those
that are in the G1 phase at the time of irradiation that are at increased
risk of enhanced chromosome damage, but the mechanism of G2
radiosensitization is at present unknown. 
There is compelling evidence that the degree or accuracy of
DNA double strand break repair can determine the levels of chro-
mosome damage in cells exposed to ionizing radiation (Pfeiffer
et al, 2000). We suggest that defects in these mechanisms may
explain the elevated levels of chromosome damage in cells strains
without TP53 mutations and with normal G1 arrest. However, for
strain 80MA, with a mutation in the hCHK2 gene, impaired G1
arrest is a more likely explanation since it had the lowest G1 arrest
value of the group 3 strains, overlapping the group 2 range. The
Chk2 protein is activated in response to ionizing radiation
(Tominaga et al, 1999) and is required to stabilize p53 transcrip-
tion (Chehab et al, 2000) so will have an influence on G1 arrest.
The fact that the induced aberration frequency in 80MA is almost
twice as high as that of the most sensitive TP53 mutation-carrying
strain suggests that Chk2 has a function in addition to the stabiliza-
tion of p53 and that this additional function influences the aberra-
tion production after irradiation. However, this interpretation of
the abnormal behaviour of strain 80MA must remain tentative
until the other non-TP53 mutant strains have been tested for
germline hCHK2 mutations. So far, only strain 107MA has been
tested and found to be without a mutation of this gene. 
In Li-Fraumeni cells with or without TP53 mutations, a reduced
capacity to eliminate or repair chromosomal damage of the type
induced by ionizing radiation, from endogenous or exogenous
sources, may contribute to cancer predisposition in this syndrome. 
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